(1)
Karki, B.; Sherpa, T. W.; Deo, R. K.; Thapa, P. Clinical Response to Rifaximin Amongst Irritable Bowel Syndrome (IBS) Patients at Tertiary Level Hospital in Nepal. JPAHS 2024, 11, 21-26.